12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

AmberGen, Werfen deal

Werfen's Inova Diagnostics Inc. subsidiary received rights to two autoantigen biomarkers for primary biliary cirrhosis...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >